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Vascular remodeling of the mouse embryonic yolk sac is a highly dynamic process
dependent on multiple genetic signaling pathways as well as biomechanical factors
regulating proliferation, differentiation, migration, cell-cell, and cell-matrix interactions.
During this early developmental window, the initial primitive vascular network of the yolk
sac undergoes a dynamic remodeling process concurrent with the onset of blood flow,
in which endothelial cells establish a branched, hierarchical structure of large vessels and
smaller capillary beds. In this review, we will describe the molecular and biomechanical
regulators which guide vascular remodeling in the mouse embryonic yolk sac, as well
as live imaging methods for characterizing endothelial cell and hemodynamic function in
cultured embryos.
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INTRODUCTION
The first functional organ system to form inmammalian embryos
is the cardiovascular system. The early establishment of the car-
diovascular network during development is a complex, morpho-
genetic process, which requires the regulation of multiple cell
types and the activation of several signal transduction pathways.
If this network is not established properly, it affects organ devel-
opment and embryo viability (Coultas et al., 2005; Udan et al.,
2013a). Furthermore, maintenance and stabilization of this com-
plex cardiovascular network must occur throughout adulthood,
as impairments in vessel integrity and hemodynamic function can
result in poor health or early death (Carmeliet, 2003).
Elucidating the physical andmolecular cues required to trigger
the morphogenetic events that occur during vascular develop-
ment has been a significant challenge to developmental biologists,
cancer biologists, physiologists, and scientists of many other disci-
plines for centuries, and has been speculated upon since the time
of Aristotle (Risau, 1997). Of particular importance is under-
standing how the physical cues imparted by hemodynamic force
affect the regulatory events and signaling pathways controlling
embryonic vessel development. Defining these mechanisms is
critical for determining how a normal vascular network develops
and how aberrant vascular development can contribute to disease.
Importantly, understanding the mechanisms by which a healthy
vasculature is established will aid in the development of clinical
and therapeutic interventions for the prevention and treatment
of cardiovascular diseases.
VASCULOGENESIS IN THE MOUSE EMBRYO
Themouse is a leadingmodel system for studying the physical and
molecular regulation of vascular development. The availability of
genetic manipulation in mice has provided a wealth of informa-
tion about the molecular pathways involved in the establishment,
remodeling and maintenance of the cardiovascular network. In
the mouse embryo, the initial establishment of blood vessels
occurs in the absence of hemodynamic force. Cells that give rise
to the first primitive vessels located in the yolk sac begin to form
during gastrulation, which occurs on mouse embryonic day 6.5
(E6.5). During this time, the epiblast, which is a single epithe-
lial cell layer, undergoes an epithelial-to-mesenchymal transition
to form the primitive streak, which gives rise to the germ lay-
ers of the embryo proper—the mesoderm, definitive endoderm,
and embryonic ectoderm (Nowotschin and Hadjantonakis, 2010;
Solnica-Krezel and Sepich, 2012). Vasculogenesis, the de novo
formation of a network of blood vessels, is the first phase of
vessel development, where blood and endothelial cell precursors
(angioblasts) migrate from the mesoderm, aggregate and form
the blood islands located in the proximal extraembryonic yolk
sac by E7.5 (Figure 1A) (Risau and Flamme, 1995; Shalaby et al.,
1997). After the blood islands have formed, angioblasts located
at the outer edges divide and differentiate into endothelial cells
and migrate distally into the yolk sac, forming a simple cap-
illary network that encompasses the yolk sac. This network of
interconnected rudimentary small vessels, homogeneous in shape
and size, is the primitive capillary plexus (Figure 1B) (Drake and
Fleming, 2000; Coultas et al., 2005; Udan et al., 2013a).
The initial establishment of the capillary plexus during vas-
culogenesis is largely dependent on activation of the vascular
endothelial growth factor (VEGF) signaling pathway. Several
genetic studies in mice identified vascular endothelial receptor
2 (VEGFR2/Flk1) as a regulator of de novo vasculogenesis, crit-
ical for the development of both blood cells and the primitive
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FIGURE 1 | Vascular development of the mouse embryonic yolk sac. (A) VEGFR2/Flk1 expression labeling nascent vessels in the blood islands at E7.5; (B)
ε-globin-GFP labeled erythroblasts filling the primitive capillary plexus at E8.5, and (C) after vascular remodeling at E9.5.
capillary plexus during embryogenesis (Klagsbrun and Soker,
1993; Dvorak et al., 1995; Poole et al., 2001; Coultas et al., 2005).
During the de novo establishment of the capillary plexus of the
yolk sac, as well as the early development of the vasculature within
the embryo proper, VEGF signaling is finely balanced to allow
for the migration and proliferation of endothelial cells into the
primitive vascular network (Leung et al., 1989; Klagsbrun and
Soker, 1993; Dvorak et al., 1995; Petrova et al., 1999; Coultas
et al., 2005; Shibuya and Claesson-Welsh, 2006). Furthermore,
the Scl/T-cell acute lymphoblastic leukemia transcription factor
(Scl), a member of the basic-helix-loop-helix (bHLH) transcrip-
tion factor family, has been identified in the specification of Flk1
positive multipotent progenitors, which give rise to both blood
and endothelial cells (Robb et al., 1995; Shivdasani et al., 1995;
Porcher et al., 1996; Visvader et al., 1998). In fact, putative Scl
binding sites have been found on the Flk1 promoter, suggesting
that Scl directly acts as a regulator of Flk1 expression andmultipo-
tent properties of early endothelial and hematopoietic progenitor
cells, critical for the establishment of the initial capillary plexus
during vasculogenesis (Kappel et al., 2000). The development of
this capillary network in the yolk sac is one of the first steps in
the sequence of highly dynamic morphogenetic events that occur
during early vascular development.
ANGIOGENESIS AND VASCULAR REMODELING IN THE
MOUSE YOLK SAC
Once the primitive capillary plexus of the yolk sac is established
by about E8.5, this honeycomb-like network of vessels undergo
rapid morphological changes to adjust to the demands of the
expanding yolk sac and growing embryo. This is an angiogenic
process, where the established vessels remodel to expand and
increase in diameter, and smaller vessels fuse to form the large
major vessels of the yolk sac and embryo (Udan et al., 2013a).
Concurrently, other vessels undergo pruning to eliminate exces-
sive branches, intussusception to create branch points in large
vessels, and nascent vessels sprout from existing larger vessels to
form small capillary beds. This morphogenetic process, known as
vascular remodeling, occurs between E8.5 and E9.5, and results
in a hierarchically branched, highly organized vascular network
(Figure 1C) that allows vessels to become low-resistance conduits
for the transport of blood, oxygen, nutrients and waste to and
from the yolk sac and embryo proper. This remodeling process
is a critical time point required for the ability of the cardiovas-
cular system to function and support the growing embryo; if the
vessels are not remodeled correctly, the viability of the embryo is
no longer sustainable. This process is regulated by both molecular
and biomechanical signaling.
Some of the most studied and earliest identified molecular
signaling pathways that are essential for angiogenesis are the
Tie family of receptor tyrosine kinases. Expression analysis of
Tie1 and Tie2 receptors show localization within the vascula-
ture from the onset of angioblast specification (E7.0), continuing
on through development and into adulthood. (Dumont et al.,
1992, 1995; Sato et al., 1993; Schnurch and Risau, 1993; Korhonen
et al., 1994). Furthermore, targeted mutations of Tie receptors
in mice revealed significant impairments on vascular develop-
ment during angiogenic processes, including yolk sac vascular
remodeling (Dumont et al., 1994; Sato et al., 1995). Although Tie
receptors were initially thought to be orphan receptors, exten-
sive studies have identified four ligands that can bind to Tie
receptors: angiopoietins 1–4, (Davis et al., 1996; Suri et al., 1996;
Maisonpierre et al., 1997; Valenzuela et al., 1999). These lig-
ands have also been shown to be necessary for the regulation
of yolk sac vascular remodeling in the mouse embryo (Davis
et al., 1996; Maisonpierre et al., 1997; Gale et al., 2002). These
data identify the Tie family of receptors and ligands as critical
molecular regulators of vascular remodeling during angiogene-
sis, after the initial establishment of the capillary plexus during
vasculogenesis.
Another example of themolecular regulation of yolk sac angio-
genesis and vascular remodeling is the transforming growth factor
β superfamily (TGFβ), which encompasses transforming growth
factors and receptors, bone morphogenetic proteins and activins
(Jakobsson and van Meeteren, 2013). Homozygous deletion of
TGFβ family members results in embryonic lethality by E10.5–
E11.5, at which point the mice are shown to have an unremodeled
yolk sac vasculature, defects in endothelial and hematopoietic dif-
ferentiation, delayed angiogenesis and weak vessels (Letterio et al.,
1994; Dickson et al., 1995; Oshima et al., 1996; Yang et al., 1999;
Oh et al., 2000; Urness et al., 2000; Larsson et al., 2001).
These genetic experiments provide examples of the individ-
ual contribution of members of the TGFβ pathway to remodeling
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of the vasculature of the yolk sac and embryo. The fine bal-
ance of activation, localization and balance of TGFβ ligands,
receptors, and downstream signal transduction molecules have
all been shown to be critical regulators of angiogenesis, vascu-
lar remodeling and vessel stability in the mouse embryo during
development.
At the conclusion of vascular remodeling, the vasculature of
the yolk sac and embryo are subdivided into a highly organized,
hierarchical network of structurally and functionally distinct
arteries and veins, each with its own specialized purpose for
the delivery of oxygen and nutrients to the developing embryo.
Although it has been hypothesized that the differential effects of
hemodynamic force of blood flow on developing vessels is a major
factor for the molecular distinction between arteries and veins (le
Noble et al., 2004), molecular markers of arterial and venous cell
fate have been identified in endothelial cells before the onset of
hemodynamic force.
The earliest identified and most studied factors which regu-
late arterial/venous identity are the Eph receptors, a large family
of receptor tyrosine kinases and their membrane-bound ligands,
the ephrins (Klein, 2012). Analysis of EphrinB2 and its recep-
tor EphB4 at the earliest stages of vascular development revealed
compartmentalized expression of EphrinB2 within the endothe-
lial cells of developing arteries, whereas expression of EphB4 is
localized to venous endothelial cells (Wang et al., 1998), suggest-
ing that the differences between arteries and veins are genetically
pre-determined and are critical for proper vascular function dur-
ing development. Furthermore, the phenotypic analysis of several
knockout mice within the Eph family of receptors and ligands
confirmed their essential role in vascular morphogenesis (Wang
et al., 1998; Gerety et al., 1999; Adams et al., 2001; Gerety and
Anderson, 2002). Researchers in the field describe the interaction
between ephrinB2 and EphB4 as reciprocal, in which signaling
between the arterial and venous compartments allows for the sep-
aration of arterial and venous cell fates, downstream of pathways
that are necessary for the establishment of arterial and venous
progenitors (Klein, 2012).
The Notch signaling pathway has been implicated as regula-
tor of arterial and venous cell fate upstream of ephrin signaling.
This family consists of the Notch receptors (Notch 1–4), which
interact with the ligands Delta-like (Dll) 1, 3, 4, Jagged1 and
Jagged2. Upon interaction between the ligand and its receptor,
the intracellular domain of the receptor is cleaved, where it can
translocate to the nucleus and activate transcription of target
genes (Gridley, 2010). Analysis of Notch ligands and their recep-
tors have identified expression in the endothelium, with many
family members restricted to the arterial compartment (Villa
et al., 2001). Targeted mutation of Notch pathway members in
mice has provided further evidence that this pathway is key in
regulating arterial endothelial cell identity and yolk sac vascular
morphology (Conlon et al., 1995; Xue et al., 1999; Krebs et al.,
2000; Fischer et al., 2004; Gale et al., 2004).
While the specification of arterial identity is regulated by a
number of different transcription factors and signalingmolecules,
specification of venous cell fate is primarily mediated through the
orphan nuclear receptor chicken ovalbumin upstream promoter-
transcription factor II (CoupTFII). Targeted deletion ofCoupTFII
inmice results in an unremodeled yolk sac vasculature and defects
in cardiac morphogenesis (Pereira et al., 1999). CoupTFII is
expressed solely in the venous compartment of the endothelium,
and upon conditional deletion of CoupTFII in endothelial cells,
expression of arterial markers is observed within venous endothe-
lial cells. Conversely, ectopic expression of CoupTFII results in the
fusion of arteries and veins. The authors conclude that CoupTFII
functions cell autonomously to suppress the activation of arterial
regulators to maintain venous cell fate (You et al., 2005).
The specification and maintenance of arterial and venous
identity is critical for viability as the embryo continues to
grow. In the absence of functional arteries and veins, circula-
tion can become impaired, highlighting the importance of the
early genetic specification and patterning of these specialized
endothelial cells before the onset of blood flow. Furthermore, after
remodeling, the newly formed vessels of the yolk sac and embryo
begin to stabilize through the recruitment of mural cells to the
endothelium, including smooth muscle cells and perictyes. This
recruitment is initiated by the secretion of platelet derived growth
factor B (PDGFB) from endothelial cells, which in turn binds to
PDGF receptors on the mural cell surface and allows them to
contribute to the stabilization and formation of the vessel wall
(Armulik et al., 2005; Gaengel et al., 2009).
THE REGULATION OF ENDOTHELIAL CELLS BY
HEMODYNAMIC FORCE DURING VASCULAR REMODELING
Physical forces imparted by blood flow are known to regulate
vascular remodeling within the yolk sac and embryo proper
(Lucitti et al., 2007; Culver and Dickinson, 2010). In vitro anal-
ysis of how endothelial cells respond to mechanical force has
been insightful in identifying mechanosensitive signal transduc-
tion pathways that can modulate endothelial cell morphology
and function (Tzima et al., 2001, 2002, 2003; Osawa et al., 2002;
Newman and Newman, 2003; Lehoux et al., 2006). For exam-
ple, the application of shear stress, the frictional force of flowing
blood dragging along the vessel wall, to cultured endothelial cells
has been shown to activate a signal transduction complex com-
posed of three receptors, VEGFR2 (Flk1), vascular endothelial
cell cadherin (VE-cadherin), and platelet endothelial cell adhe-
sion molecule 1 (PECAM1) in vitro (Tzima et al., 2005). When
a confluent monolayer of endothelial cells in culture is exposed
to laminar (steady, non-turbulent) flow, endothelial cells realign
parallel to the direction of flow. Although previous work had indi-
cated this phenomenon was dependent solely on the activation
of the phosphatidylinositol-3-OH kinase (PI3K) pathway through
Flk1 (Shay-Salit et al., 2002), the authors demonstrated that upon
deletion of either VE-cadherin or PECAM1 in confluent endothe-
lial monolayers exposed to flow, the cells were no longer able to
respond to the shear stress and did not realign in the direction of
flow. Furthermore, upon overexpression of Flk1, PECAM1, and
VE-cadherin in cells which do not respond to mechanical shear
stress normally, cells realigned parallel to the direction of flow,
becoming mechanosensitive (Tzima et al., 2005). These data pro-
vided evidence of a molecular complex that is triggered solely by
mechanical force, which serves as a necessary cue for the ability
of endothelial cells to change morphology and polarity within a
cultured monolayer. The authors concluded that the mechanism
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for activation of this mechanosensory complex is through direct
transmission of mechanical force via PECAM1 to VE-cadherin,
which acts as an adaptor protein activating Flk1 and catalyz-
ing the activation of the PI3K signaling cascade. Furthermore,
in vitro experiments using FRET (fluorescence resonance energy
transfer) biosensors showed increased force acting on PECAM1
at junctions upon the addition of shear stress, further support-
ing the idea of PECAM1 as a mechanosensitive signaling factor
(Conway et al., 2013). Whether this complex is activated in a
similar way in vivo has yet to be determined, but it is known
that some of these receptors are essential for embryonic vascular
development. As described earlier, Flk1 is critical for the ear-
liest stages of both vasculogenesis and hematopoiesis (Shalaby
et al., 1997), and VE-cadherin is necessary for vascular morpho-
genesis (Gory-Faure et al., 1999). However, while PECAM1 is
expressed in the endothelium during embryonic vascular devel-
opment, genetic deletion of this gene shows no deficiencies in
vasculogenesis, angiogenesis, or vascular remodeling (Duncan
et al., 1999), indicating the mechanism by which hemodynamic
force regulates vascular remodeling in vivomay rely on additional
factors. Furthermore, several in vitro experiments performed
to determine the mechanism behind the mechanosensitivity of
endothelial cells have identified a wide array of proteins, includ-
ing ion channels, G-protein coupled receptors, nitric oxide release
molecules, and signaling transduction pathways, all of which may
play a potential role in the regulation of vascular remodeling in
vivo (Lehoux et al., 2006; Culver and Dickinson, 2010).
The characterization and quantification of how hemodynamic
force regulates mouse yolk sac vascular remodeling in vivo has
been largely aided by the application of imaging techniques and
live embryo culture, which will be discussed later in this review
(Jones et al., 2004, 2005; Larina et al., 2008, 2009a; Udan et al.,
2013b). It is known that in the mouse, upon the initiation of the
heartbeat at E8.25 (∼3 somites) and the entry of blood cells into
the circulation (∼6 somites), hemodynamic force plays a criti-
cal role in the regulation of endothelial cell function and vascular
remodeling, forming a low-resistance, highly organized yolk sac
vasculature. The direct role of the onset of blood flow at this
early stage of vascular development has been studied for several
years and is still highly debated; some suggested that blood flow
is necessary for the transport of oxygen to the growing embryonic
tissue, while others suspected blood flow in the nascent vascula-
ture is required for the transport of soluble nutrients and growth
factors essential for proper endothelial cell function (Conway
et al., 2003). However, it was also increasingly clear through
in vitro experiments that shear stress, and therefore hemodynamic
force, is a critical physical factor in the regulation of endothelial
cell function. Shear stress (τ), the primary hemodynamic force
required for vessel remodeling, is quantified by multiplying the
apparent viscosity (μapp) of blood by the shear rate (γ), which
is dependent on the velocity gradient of blood flow at the ves-
sel wall and the vessel radius (Jones et al., 2004). Based on this
definition, deficiencies in heart development, cardiac output, or
hematopoiesis in the developing embryo affect the shear stress
on a vessel wall, which can in turn significantly affect endothe-
lial cell function and the ability of vessels to remodel during
development.
Indeed, a number of mice with mutations causing deficien-
cies in early cardiac development and function are embryonic
lethal due to impairments in vascular remodeling (Tanaka et al.,
1999; Wakimoto et al., 2000; Koushik et al., 2001; Huang et al.,
2003; May et al., 2004). For example, mutation of the gene
atrial myosin light chain 2a (mlc2a), a structural component of
the atrial myofibrillar apparatus, confers significantly reduced
atrial contraction and reduced hemodynamic force (low, oscil-
latory flow), resulting in lethality by E10.5–11.5. Not only do
embryos display cardiac morphogenesis abnormalities, but also
a completely unremodeled yolk sac vasculature at E9.5 (Huang
et al., 2003). Similarly, deletion of the Na+/Ca2+ exchanger
(Ncx1) causes a complete lack of heartbeat and shows deficien-
cies in vascular remodeling (Wakimoto et al., 2000; Koushik et al.,
2001). Furthermore, deletion of the homeobox transcription fac-
tor Nkx2.5, a regulator of dorsal mesoderm specification, results
in impaired cardiac development after looping, defects in vascu-
lar remodeling in the yolk sac and embryo, and impairments in
hematopoiesis. Interestingly, the authors demonstrated through
chimera studies that vascular remodeling failure can be rescued
if wild type Nkx2.5 cardiomyocytes constitute greater than 85%
of the heart (Tanaka et al., 1999), suggesting that cardiac func-
tion alone can play a significant role in the ability of vessels to
remodel. Finally, embryos with mutations in the cardiomyocyte
protein Titin, which acts as a spring during muscle contraction,
have impaired blood flow, and endothelial cells of the yolk sac
and embryo proper display defects in cell morphology, including
irregular cell-cell contact and abnormal spatial distribution dur-
ing vasculogenesis and angiogenesis (May et al., 2004). These data
demonstrate the significance of cardiac output and its contribu-
tion to hemodynamic force during vascular development. In the
absence of a strong heartbeat and the corresponding pulsatile, for-
ward movement of blood flow within the capillary plexus, vessels
within the yolk sac fail to remodel, and the embryo can no longer
sustain growth resulting in lethality.
Shear stress imparted on blood vessels is dependent not only
on blood velocity/cardiac output, but also on blood viscosity,
which is correlated with the concentration of red blood cells
within the circulation. The entry of blood cells into the embry-
onic circulation at ∼6 somites is a necessary physiological cue
for the induction of vascular remodeling. A number of gene
mutations have been reported that result in the absence of
hematopoietic development, where as a consequence, the vas-
culature fails to remodel (Robb et al., 1995; Matsumoto et al.,
2006; He et al., 2008; Satyanarayana et al., 2010). For exam-
ple, knockout of Scl, which encodes a bHLH transcription factor
identified in T-cell leukemia, results in lethality by E9.5, due to
significant developmental delay, edema, a complete absence of
hematopoiesis, and an unremodeled yolk sac vasculature, sug-
gesting that a significant reduction in blood development can
impair yolk sac vascular remodeling (Robb et al., 1995). Similarly,
deletion of the transcription factor Krüppel-like factor 6 (Klf6),
which regulates cell proliferation, resulted in a drastic reduc-
tion in hematopoietic cell production and a poorly organized
yolk sac vasculature. Upon the production of Klf6−/− embry-
onic stem cells, it was determined that Klf6 deletion resulted
in a reduced capacity in hematopoietic lineage differentiation,
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while endothelial cell differentiation and expression remained
unchanged (Matsumoto et al., 2006). More recently, deletion of
the guanine nucleotide exchange factor RapGEF2, which activates
Rap1, resulted in severe defects in yolk sac vascular remodeling.
Although the vasculature failed to remodel, there were no changes
in Flk1+ (endothelial) cells within the yolk sac, but a significant
reduction in CD41+ (hematopoietic) cells, indicating the early
blood and endothelial cell progenitors are still present, but main-
tenance of hematopoiesis no longer occurs (Satyanarayana et al.,
2010). Also, conditional deletion of the proto-oncogene, c-myc
in early blood and endothelial cell precursors resulted in a lack
of early hematopoietic lineages, an impairment in definitive
hematopoiesis, and deficient angiogenesis and yolk sac vascular
remodeling. Furthermore, conditional c-myc deletion played no
role in the establishment of the vascular plexus during angiogen-
esis, and had no effect on endothelial cell proliferation, migration
or survival (He et al., 2008). These data indicate that the devel-
opment of blood cells and their entry into the circulation at
the onset of cardiac contraction is a physical trigger necessary
for regulating dynamic endothelial cell function during vascular
remodeling.
While there is strong evidence that cardiac output and the vis-
cosity of blood are both necessary mechanical triggers for the
activation of vascular remodeling through shear stress, until the
past decade, there was no definitive answer to whether the onset
of blood flow triggered yolk sac vascular remodeling through a
purely mechanical mechanism in the mouse embryo. To answer
this question in vivo, primitive erythroblasts were sequestered to
the blood islands in cultured wild type embryos before the onset
of blood flow through acrylamide polymerization, which reduced
viscosity and shear stress within the circulation. In the absence of
circulating red blood cells in cultured wild type embryos, the yolk
sac capillary plexus did not remodel, and expression of endothe-
lial nitric oxide synthase (eNOS), a known mechanosensitive
protein, was significantly reduced. Furthermore, the remodeling
defects and decreased eNOS expression levels observed in the cul-
tured embryos with sequestered erythroblasts were rescued by the
injection of a viscous material, hetastarch, into the circulation,
which compensated for the lack of circulating blood cells (Lucitti
et al., 2007). These studies show that the physical trigger of hemo-
dynamic force and shear stress acting upon the endothelium is
both necessary and sufficient to activate vascular remodeling in
the mouse yolk sac.
LIVE IMAGING OF VASCULAR REMODELING AND
HEMODYNAMICS IN THE MOUSE EMBRYO
Traditional developmental biology approaches to understand-
ing how the vasculature changes over time during remodel-
ing have taken advantage of immunohistochemistry and in situ
hybridization to observe protein and gene expression within the
endothelium at fixed time points. However, limiting observa-
tion to snapshots in time using these methods does not allow
us to capture the complex, dynamic spatio-temporal changes of
the remodeling vasculature. Since the advent of fluorescent pro-
teins and genetic manipulation, the use of imaging techniques
has been widely adapted for live analysis, such as cell migra-
tion, membrane dynamics, proliferation, and apoptosis. In vivo
analysis of such cellular properties in the mouse during early
development remains a significant challenge, due to the closed
nature of mammalian in utero development. Within the past
decade, mouse developmental biologists have begun to circum-
vent this limitation by combining embryo culture with imaging
techniques to study vascular morphogenesis and hemodynamics
in living embryos (Jones et al., 2004, 2005; Lucitti et al., 2007;
Larina et al., 2008, 2009a; Garcia et al., 2011; Udan et al.,
2013b).
Confocal microscopy has been used to image dynamic
changes within the mouse yolk sac vasculature during remodel-
ing. Transgenic mice expressing endothelial specific fluorescent
reporters labeling the nucleus (Flk1-H2B::YFP) (Fraser et al.,
2005) and the membrane (Flk1-myr::mCherry) (Larina et al.,
2009b) have provided a straightforward imaging method to assess
cell migration and vascular morphogenesis in cultured embryos
(Figure 2). Embryonic imaging of these models in static culture
on the imaging stage allows for visualization of the vascula-
ture outline (labeled by the mCherry reporter) and tracking of
all endothelial cells within the field of view, and has been used
to study how endothelial cells respond to hemodynamic force
during vascular remodeling (Udan et al., 2013b). Through time-
lapse confocal microscopy, it has been shown that vessel diameter
increases observed in the yolk sac vitelline artery during vas-
cular remodeling are dependent on hemodynamic force, and
are due to directed endothelial cell migration and vessel fusion
events. Furthermore, when analyzing endothelial cell dynamics
in blood flow-impaired mutant mice, the ability of endothelial
cells to migrate and fuse to form larger vessels was lost. The
dynamic endothelial behaviors observed using live imaging tech-
niques have contributed to our knowledge of how endothelial
cells respond to mechanical forces within the yolk sac during
development, and highlighted the potential of live imaging for
a more complete understanding of vascular morphogenesis in
mouse embryos.
Time lapse microscopy of morphogenetic processes that occur
over several hours can be easily performed using any number
of conventional fluorescent microscopes. However, capturing the
rapid, dynamicmovement of blood flowing through a vessel using
FIGURE 2 | In vivo labeling of the yolk sac vasculature using vital
fluorescent reporters. The embryonic yolk sac vasculature of transgenic
mice, labeling the membrane (Flk1-myr::mCherry), and nuclei
(Flk1-H2B::YFP) of endothelial cells. (A,B) Vascular plexus of the embryonic
yolk sac at E8.5 at 10× and 40× (oil) magnification, respectively.
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fluorescence microscopy can be challenging due to the high frame
rate needed to resolve individual blood cells in time. Traditional
confocal microscopes can be used for the acquisition and quan-
tification of blood flow by repetitive, single line-scanning either
parallel or perpendicular to the direction of flow (Dirnagl et al.,
1992; Kleinfeld et al., 1998; Jones et al., 2004). However, this
imaging technique provides a limited number of data points
and rigorous validation. The development of line-scanning con-
focal microscopes allows for the rapid, real-time acquisition of
blood flow in vivo (Dirnagl et al., 1992; Kleinfeld et al., 1998;
Jones et al., 2004; Larina and Dickinson, 2012). Through the
use of slits instead of conventional pinholes, line scanning con-
focal microscopes such as the Zeiss LSM 7 LIVE, which utilizes
line illumination and a linear detector, have a frame rate of up
to 120 frames per second. This rapid frame acquisition is ideal
for imaging and tracking individual blood cells within a ves-
sel over multiple frames for the quantification of blood velocity
in the mouse yolk sac. Blood cells can be visualized in cul-
tured embryos using the transgenic reporter mouse ε-globin-GFP,
which brightly labels primitive erythroblasts during embryonic
development (Figure 3A) (Dyer et al., 2001). Such fast frame rates
allow cells to be easily distinguishable and traceable (Figure 3B),
allowing a large number of cells per time lapse to be used for
hemodynamic quantification, including peak blood velocity, aver-
age blood velocity, full blood velocity profiles, and heart rate
(Figure 3C). This imaging technique provides a powerful tool for
studying mouse mutants with impairments in vascular remod-
eling, helping to determine the direct cause of remodeling failure
and distinguish between poor hemodynamics and endothelial cell
dysfunction.
Visualization of blood flow using confocal microscopy requires
the use of fluorescent reporters or dyes through transgenic mice
and/or embryo manipulation, which require time for breeding
or is invasive. An alternative optical imaging technique, optical
coherence tomography (OCT) takes advantage of interferome-
try to acquire images using natural optical tissue contrast, and
does not require fluorescent proteins, dyes or contrast agents.
OCT has the capability of imaging 2–3mm into tissue, which
enables deeper imaging within the cultured embryo, though with
lower spatial resolution (∼2–15μm). We previously described
the use of Doppler OCT to directly quantify blood velocity in
the superficial vessels of the yolk sac, as well as deeper vessels
within cultured embryos at E8.5 and E9.5 (Figure 4) (Chen et al.,
1997). If the direction of the blood flow is known, blood flow
FIGURE 3 | Hemodynamic analysis in the embryonic yolk sac. (A)
Cultured embryos with erythrocytes labeled using the ε-globin-GFP
transgene near the blood islands at E8.5. (B) Tracks of all cells detected using
image processing software during the movie represented in (A). The colored
lines represent the position of the blood cells over the course of the time
lapse. (C) Plot of individual cell velocities over the course of the time lapse.
This allows for the quantification of average blood velocity, peak blood
velocity, velocity profiles, and heart rate.
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FIGURE 4 | Live hemodynamic analysis with Doppler OCT in cultured
mouse embryos at E9.5. (A) Structural image of an E9.5 embryo
showing fragments of the yolk sac and embryonic trunk. (B)
Corresponding color-coded Doppler OCT image showing strong signals
produced by blood flow in the yolk sac vessel and dorsal aorta.
Different colors indicate opposite directions of the flow in these
structures. (C,E) Blood flow velocity profiles and (D,F) dynamics of the
peak blood flow velocity in the yolk sac vessel and dorsal aorta,
respectively, measured along the lines shown in (A) at different phases
of the heartbeat cycle. Adapted from Larina et al. (2008).
at each pixel of an OCT image can be reconstructed. During
vascular remodeling, blood velocity within the yolk sac and
embryonic vessels is robust, allowing for a strong Doppler sig-
nal and an easy and reliable measurement of blood velocity in
cultured embryos. Doppler OCT images are pseudocolored to
indicate opposing blood flow directions in vessels (Figures 4A,B).
Velocity measurements across both vessels result in a distinct
parabolic velocity profile associated with blood flow, with the
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peak blood velocities at the center of the vessel, similar to that
observed using confocal microscopy (Figures 4C,E). Analysis and
quantification of the cardiac cycle can be performed by plot-
ting the peak blood velocity observed within the vessel over time
(Figures 4D,F). Hemodynamic data obtained by Doppler OCT
in cultured mouse embryos has been validated as comparable
to measurements made using fast-scanning confocal microscopy
(Jones et al., 2004; Larina et al., 2008). Furthermore, while hemo-
dynamic analysis of extraembryonic yolk sac vessels is relatively
simple using confocal microscopy, the imaging depth limitations
associated with fluorescence microscopy does not allow anal-
ysis of vessels deep within the embryo; this problem can be
overcome using OCT. Also, analysis of OCT speckle variance
within vessels in cultured embryos can be used to reconstruct
the 3-D structure of the yolk sac and embryonic vasculature
(Sudheendran et al., 2011; Mahmud et al., 2013). The develop-
ment and use of OCT as an imaging tool for cultured embryos,
specifically for cardiodynamic assessment, allows scientists to
image deeper into the embryo without the need for fluores-
cent reporters, dyes or contrast agents, to answer fundamen-
tal questions about cardiovascular form and function in living
mammalian embryos.
CONCLUSION
Vascular remodeling, in which the primitive capillary plexus of
the yolk sac is remodeled to form a branched hierarchical net-
work of arteries, veins, and capillary beds, is a critical step in
early cardiovascular development. As described in this review,
impairments in this process can be due to defects in endothe-
lial cell function that can inhibit the ability of the vasculature to
respond to cues from signaling molecules, nutrients or physical
forces. Secondarily, defects in hemodynamic force, either through
altered cardiac output or hematocrit content, can also inhibit the
ability of the vasculature to remodel. Although yolk sac vascu-
lar remodeling defects are fairly common, it is often the case
that the direct cell type or mechanism for the impaired remod-
eling phenotype is not fully understood. Conditional knockout
approaches directly targeting endothelial cells, cardiomyocytes,
and/or hematopoietic cells, as well as imaging techniques, such
as those described in this review, for in vivo analysis of hemo-
dynamics and endothelial cell migration are all necessary when
understanding the mechanism behind the complex morpho-
logical and molecular events that occur during vasculogenesis,
angiogenesis, and vascular remodeling.
Basic research in vasculogenesis and angiogenesis has been
supported by its clinical relevance, in which we can adapt what
we learn to disease states such as cancer, atherosclerosis, and
osteoporosis. Although a lot is known about the signal transduc-
tion pathways that regulate both vasculogenesis and angiogenesis,
new genes are discovered every day, which can contribute to the
regulation of endothelial cell function, vascular morphogenesis,
and vascular homeostasis. Continuing studies that take advan-
tage of animal disease models and genetic manipulations will
be necessary to continue to elucidate the complexities of sig-
nal transduction and gene regulation during embryonic vascular
development, to provide new gene targets and therapeutics for
health intervention in the clinic.
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